162,388 research outputs found

    R. Lafontaine, P. Piret, J.-N. Aletti, Y. Simoens, C. Theobald, P. Gibert, J.-M. Hennaux, J.-P. Sonnet, A.-M. Pelletier & A. Chapelle, L'Écriture âme de la théologie (coll. LE. T., 9)., 1990

    No full text
    Focant Camille. R. Lafontaine, P. Piret, J.-N. Aletti, Y. Simoens, C. Theobald, P. Gibert, J.-M. Hennaux, J.-P. Sonnet, A.-M. Pelletier & A. Chapelle, L'Écriture âme de la théologie (coll. LE. T., 9)., 1990. In: Revue théologique de Louvain, 25ᵉ année, fasc. 1, 1994. p. 78

    [Report to Chief J. E. Curry, by an unknown author #1]

    No full text
    Report to Chief J. E. Curry, by an unknown author. The report contains a list of officers who gave depositions to the United States Attorney

    [Report to Chief J. E. Curry, by an unknown author #2]

    No full text
    Report to Chief J. E. Curry, by an unknown author. The report contains a list of officers who gave depositions to the United States Attorney

    Advice and instructions for the prevention and cure of fever, which is prevalent in the low districts of the Transvaal, in Delagoa Bay and East Africa

    No full text
    leyds-60-7333.pdf created from original pamphlet in the WJ Leyds Collection held in the Africana Section of the Stellenbosch University Library and Information Service.Advice and instructions from Dr. J.A. Simoens of Barberton, on how to prevent and cure malarial and typhoid fever, which is prevalent in the low districts of the Transvaal, in Delagoa Bay and East Africa

    David Meyer, Yves Simoens, Soheib Bencheikh, Les versets douloureux. Bible, Évangile et Coran entre conflit et dialogue. Interview finale par J. Scheuer, (L’Autre et les autres, 9) Bruxelles, Lessius

    No full text
    Dean Jason Richard. David Meyer, Yves Simoens, Soheib Bencheikh, Les versets douloureux. Bible, Évangile et Coran entre conflit et dialogue. Interview finale par J. Scheuer, (L’Autre et les autres, 9) Bruxelles, Lessius. In: Revue d'histoire et de philosophie religieuses, 89e année n°1, Janvier-Mars 2009. p. 108

    Murder on the mountain: author talk with Peter J. Wosh

    No full text
    Author talk by Peter J. Wosh on May 5th, 2022, on his book, "Murder on the Mountain: crime, passion, and punishment in gilded age New Jersey.

    A Monolithic Visible, Infrared and Terahertz 2D Detector

    No full text
    A monolithic multispectral detector for imaging in the visible (VIS), infrared (IR) and terahertz (THz) ranges has been designed for operation at room temperature. This sensor is composed of a CMOS readout integrated circuit (ROIC) housing visible photodiodes and of IR and THz microbolometer pixels processed above the CMOS wafer. Without package- and system-level issues, targeted individual pixel sensitivities are respectively an 80dB dynamic range for VIS photodiodes, a NETD=50mK @f/1 for IR and a THz NEP smaller than 10pW. Prototyping chips will be integrated in tri-spectral imaging and THz spectroscopy demonstration system

    Mr. Melvin J. Collier, RWWL AUC, June 2011

    No full text
    This video is a conversation with Mr. Melvin J. Collier. Mr. Collier talks about his book, "From Mississippi to Africa: A Journey of Discovery". Daniel Le, AUC Woodruff Library, is the interviewer

    Compulsory licensing for expensive medicines

    No full text
    Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R, Barbier L, Simoens S, Pouppez C, Cleemput I, Vinck I. Compulsory licensing for expensive medicines. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. D/2022/10.273/35. This document is available on the website of the Belgian Health Care Knowledge Centre

    Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? : findings from across Europe and their implications

    No full text
    Generic atypical antipsychotic drugs offer health authorities opportunities for considerable savings. However, schizophrenia and bipolar disorders are complex diseases that require tailored treatments. Consequently, generally there have been limited demand-side measures by health authorities to encourage the preferential prescribing of generics. This is unlike the situation with hypertension, hypercholaesterolaemia or acid-related stomach disorders.The objectives of this study were to compare the effect of the limited demand-side measures in Western European countries and regions on the subsequent prescribing of risperidone following generics; to utilise the findings to provide future guidance to health authorities; and where possible, to investigate the utilisation of generic versus originator risperidone and the prices for generic risperidone. Principally, this was a segmented regression analysis of retrospective time-series data of the effect of the various initiatives in Belgium, Ireland, Scotland and Sweden following the introduction of generic risperidone. The study included patients prescribed at least one atypical antipsychotic drug up to 20 months before and up to 20 months after generic risperidone. In addition, retrospective observational studies were carried out in Austria and Spain (Catalonia) from 2005 to 2011 as well as one English primary care organisation (Bury Primary Care Trust (PCT)). There was a consistent steady reduction in risperidone as a percentage of total selected atypical antipsychotic utilisation following generics. A similar pattern was seen in Austria and Spain, with stable utilisation in one English PCT. However, there was considerable variation in the utilisation of generic risperidone, ranging from 98% of total risperidone in Scotland to only 14% in Ireland. Similarly, the price of generic risperidone varied considerably. In Scotland, generic risperidone was only 16% of pre-patent loss prices versus 72% in Ireland. Consistent findings of no increased prescribing of risperidone post generics with limited specific demand-side measures suggests no 'spillover' effect from one class to another encouraging the preferential prescribing of generic atypical antipsychotic drugs. This is exacerbated by the complexity of the disease area and differences in the side-effects between treatments. There appeared to be no clinical issues with generic risperidone, and prices inversely reflected measures to enhance their utilisation
    corecore